<DOC>
	<DOCNO>NCT02453126</DOCNO>
	<brief_summary>This protocol address central hypothesis fibrostenotic Eosinophilic Esophagitis ( EoE ) characterize abnormal esophageal structure compliance compare non fibrostenotic EoE distinctive cellular molecular profile predict fibrostenotic phenotype . This study aim define ass change occur structure dynamic esophageal wall pediatric Eosinophilic Esophagitis along characterize histologic molecular pattern fibrostenotic EoE .</brief_summary>
	<brief_title>Fibrostenotic Eosinophilic Esophagitis : Assessment Tools</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<criteria>Scheduled undergo clinical upper endoscopy biopsy Known connective tissue disorder Increased risk bleed Inflammatory bowel disease , celiac disease , eosinophilic gastroenteritis , autoimmune disease Other esophageal disease include know achalasia ; history caustic ingestion , esophageal surgery esophageal stricture know reason esophageal injury . Use oral intravenous steroid precede 60 day . ( Swallowed topical fluticasone , budesonide , etc include exclusion criterion . )</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Eosinophilic Esophagitis</keyword>
	<keyword>Esophageal Stricture</keyword>
</DOC>